Frequency and Magnitude of Co-payments Exceeding Prescription Drug Costs
نویسندگان
چکیده
منابع مشابه
Trends in Medicaid Prescription Drug Utilization and Payments, 1990-97
The rising cost of prescription drugs has caused public officials to restructure prescription drug coverage and payment policies in Medicaid. This study examines Medicaid utilization and payments for prescription drugs from 1990 to 1997. Medicaid prescription drug payments grew from $4.4 billion in 1990 to almost $12 billion in 1997, representing an average annual increase of 15.3 percent. In 1...
متن کاملDiagnosis-Based Risk Adjustment for Medicare Prescription Drug Plan Payments
The 2003 Medicare Prescription Drug, Improvement, and Modernization Act (MMA) created Medicare Part D, a voluntary prescription drug benefit program. The benefit is a government subsidized prescription drug benefit within Medicare. This article focuses on the development of the prescription drug risk-adjustment model used to adjust payments to reflect the health status of plan enrollees.
متن کاملPrescription drug costs and the generic dispensing ratio.
BACKGROUND The generic dispensing ratio (GDR)-the number of generic fills divided by the total number of prescriptions-is a standard performance metric on which pharmacy benefit designs and their managers are routinely evaluated. Higher GDRs are considered important because they consistently produce lower prescription drug costs. OBJECTIVE To (a) quantify the relationship between GDR and gros...
متن کاملCoronary Angioplasty with Drug-Eluting Stents: Device Costs, Hospital Costs, and Insurance Payments
Technology (BCHT) has been working with the Integrated Healthcare Association (IHA) on its Value–Based Purchasing of Medical Devices (VBP) project, which has included the collection and analysis of hospital and patient data on seven major orthopedic, cardiac, and spine procedures. This Issue Brief is the fi fth in a series that comes out of this project and presents fi ndings on implant costs, ...
متن کاملThe costs of a Medicare prescription drug benefit.
This paper describes a preliminary cost estimate, prepared by the Congressional Budget Office (CBO), of President Clinton's 1999 prescription drug benefit proposal. The CBO estimated that the new benefit would increase net Medicare outlays by $136 billion between 2002 and 2009, although these estimates are highly uncertain. Because the proposal included an annual cap on the amount of the benefi...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: JAMA
سال: 2018
ISSN: 0098-7484
DOI: 10.1001/jama.2018.0102